Medium materiality6/10
Medpace resumed with a Neutral at UBS
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Medpace resumed with a Neutral at UBS
- MEDP target: $673; current price: $622.11; Neutral.
Key facts
- 01
Target: $673
- 02
Posted price: $622.11
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.